RxDoctor Payments Data

Catherine Lindsay, MD

Family Medicine · Jacksonville, FLNPI 1639369598

Payments from drug & device makers

$14,000in general payments, 2019–2025

Across 890 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$973
  • Lilly USA, LLC$937
  • Optinose US, Inc.$930
  • Boehringer Ingelheim$824
  • plus $6K from 48 others

What the payments were for

  • Food & beverage$13,86599%
  • Education$1351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)214$2,495
Novo Nordisk116$1,442
AstraZeneca53$973
Lilly USA, LLC60$937
Optinose US, Inc.56$930
Boehringer Ingelheim53$824
Amarin Pharma, Inc.40$653
GSK33$633
Pfizer21$394
Biohaven Pharmaceuticals, Inc.16$350
Daiichi Sankyo Inc.15$322
Avanir Pharmaceuticals, Inc.16$304
Bayer15$302
Corcept Therapeutics13$285
Biohaven Pharmaceutical Holding Company Ltd.9$255
Eisai Inc.16$218
Shield Therapeutics Inc7$204
Takeda Pharmaceuticals U.S.A., Inc.14$190
Astellas Pharma US Inc5$179
Abbott9$172
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$169
Amgen9$139
Exact Sciences7$137
Vivus LLC7$123
Dynavax Technologies Corporation4$118
Sanofi-aventis U.S. LLC6$115
Johnson & Johnson8$111
IBSA Pharma Inc.7$106
Merck5$100
Idorsia Pharmaceuticals US Inc6$87
Shire North American Group Inc1$68
Adlon Therapeutics L.p.4$68
Esperion Therapeutics, Inc.3$54
Currax Pharmaceuticals LLC2$50
Axsome Therapeutics, Inc.2$43
Azurity Pharmaceuticals, Inc.2$41
Concordia Pharmaceuticals Inc.3$38
Ironwood Pharmaceuticals, Inc2$38
Clarus Therapeutics Inc.2$31
Endo Pharmaceuticals Inc.2$31
Kowa Pharmaceuticals America, Inc.2$30
Hikma Pharmaceuticals USA2$29
Aimmune Therapeutics, Inc.1$25
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Inspire Medical Systems, Inc.1$21
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Otsuka America Pharmaceutical, Inc.1$18
Genentech USA, Inc.1$18
Sumitomo Pharma America, Inc.1$17
Dermira, Inc.1$14
Sanofi Pasteur Inc.1$14
Amneal Pharmaceuticals LLC1$14
Arbor Pharmaceuticals, Inc.1$14
Redhill Biopharma Inc.1$13

How this compares

$14,000 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$74,857
Medicare patients
127
Services billed
796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin69$78,556
OzempicSemaglutide31$48,129
FarxigaDapagliflozin Propanediol39$35,899
MounjaroTirzepatide21$28,526
TradjentaLinagliptin20$16,585
RybelsusSemaglutide13$14,867
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,721
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,113
Candesartan Cilexetil47$3,272
Rosuvastatin Calcium202$1,963
Atorvastatin Calcium238$1,544
Levothyroxine Sodium162$1,459
Nebivolol Hcl21$1,384
Amlodipine Besylate227$1,294
Wixela InhubFluticasone Propion/Salmeterol16$1,270

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$824$100,254100 claims
Novo NordiskOzempic, Rybelsus$1,442$62,99644 claims
AstraZenecaFarxiga$973$35,89939 claims
Lilly USA, LLCMounjaro$937$28,52621 claims
GSKTrelegy Ellipta$633$11,72118 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$1,459162 claims
AbbVieSynthroid$2,495$75116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →